Michelle is great to work with, knows the market access landscape in detail and is an excellent partner in strategic and tactical planning and in developing collaborations with a diverse group of stakeholders.

Dr Jon Beachamp, Vice President, Medical Affairs, Efgartigim

Recently, I have had the pleasure of collaborating with Michelle on an ambitious medicines policy project. She has brought fresh ideas and a creative approach to stakeholder engagement, all with a strong focus on building consensus and developing meaningful, realistic recommendations.

Natalie Frankish, Policy and Engagement Manager for Scotland

Michelle has an unwavering commitment to improve access pathways for patients with rare diseases in Scotland. She builds strong, strategic relationships with key stakeholders and has an in-depth understanding of the rare disease patient journey and the access landscape in Scotland.

Sara Trafford-Jones, VP International Commercial Lead China

Michelle's knowledge and expertise in the rare disease arena is excellent and she has written some fantastic stuff for us, blogs, papers, policy and grant applications that have begun to make a huge difference to the way we work, the way we view ourselves and the way we are seen.

Helena Baker, Co-Founder and Advisor at Rare Disease Nurse N

Michelle has a deep expertise regarding the market access and health policy environment for rare disease medicines in the devolved nations. She is a natural networker with the finely tuned ability to seek and find partnership solutions, developing new ideas and thinking collaboratively.

Esther Nzenza, Founder and CEO of Decisive Consulting Ltd

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Decline Accept